LifeWave Biomedical is developing a digital therapeutic product that improves the management of patients diagnosed with congestive heart failure (CHF), acute respiratory distress syndrome (ARDS) and chronic obstructive pulmonary disease (COPD) in hospital, ambulatory, and home settings.

The solution consists of a small non-invasive sensor that will deliver accurate and absolute measurement of lung fluids and respiration parameters with a brief daily assessment. The data is uploaded to a smartphone/tablet application and integrated with the patient's drug regimen and other measured physiologic parameters to provide hospitalization decision support and to enhance patient self‑management.

The LifeWave smartphone/tablet application integrates with a cognitive computing solution to support artificial intelligence driven analytics and the development of a population health database. The clinical and economic benefits of the solution are the improvement of patient quality-of-life, potential extension of life expectancy, and the reduction of health care cost associated with initial hospital admissions and re‑admissions.